NORD
Nordicus Partners Corporation operates as publicly traded business accelerator and holding company for Nordic life sciences companies in the United States. The company focused on developing medicines supporting oral health. It also provides corporate finance activities, including business and market development, growth strategies, talent acquisition, partnership building, capital raising, and facilitating company acquisitions and sales. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q3 | -0.07 | $0 | -$1M |
| 2025 Q2 | -0.08 | $0 | -$2M |
| 2025 Q1 | -0.07 | $0 | -$425,698 |
| 2025 Q4 | 0.08 | $0 | -$368M |
| 2024 Q3 | -0.26 | $2,500 | $367M |
| 2024 Q2 | -0.10 | $2,500 | -$599,823 |
| 2024 Q1 | -0.04 | $0 | -$217,549 |
| 2024 Q4 | -0.01 | $2,500 | $368M |